RxDoctor Payments Data

Gladstone Payton, DO

Family Medicine · Mount Clemens, MINPI 1184617854

Payments from drug & device makers

$580in general payments, 2019–2025

Across 34 payments — averaging $17.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$250
  • AbbVie$57
  • Takeda Pharmaceuticals U.S.A., Inc.$56
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$54
  • Idorsia Pharmaceuticals US Inc$35
  • Lilly USA, LLC$34
  • plus $94 from 5 others

What the payments were for

  • Food & beverage$580100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$580 in reported general payments places this provider in the 60th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$110,906
Medicare patients
122
Services billed
9,090

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide26$34,338
EliquisApixaban24$13,355
TrintellixVortioxetine Hydrobromide27$12,780
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog19$11,043
Pentoxifylline138$6,599
Breo ElliptaFluticasone/Vilanterol13$6,382
Acyclovir14$6,197
Novolog FlexpenInsulin Aspart12$5,371
Combivent RespimatIpratropium/Albuterol Sulfate11$5,058
Megestrol Acetate43$4,621
Diclofenac Sodium-MisoprostolDiclofenac Sodium/Misoprostol18$4,610
FenofibrateFenofibrate Nanocrystallized151$4,366
NovologInsulin Aspart16$3,415
AliskirenAliskiren Hemifumarate14$3,217
Levetiracetam36$2,372

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$34$34,33826 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$56$12,78027 claims
Novo NordiskNovolog$250$3,41516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Mount Clemens

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →